Amphastar Pharmaceuticals, Inc. Logo

Amphastar Pharmaceuticals, Inc.

Develops and manufactures complex injectable, intranasal, and inhalation pharmaceutical products.

AMPH | US

Overview

Corporate Details

ISIN(s):
US03209R1032 (+3 more)
LEI:
54930055TH0ZLSAQMJ38
Country:
United States of America
Address:
11570 SIXTH STREET, 91730 RANCHO CUCAMONGA
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Amphastar Pharmaceuticals, Inc. is a biopharmaceutical company focused on the development, manufacturing, and marketing of complex and technically challenging pharmaceutical products. The company's portfolio primarily consists of generic and proprietary injectable, intranasal, and inhalation drugs. It specializes in complex medications, including biologics, interchangeable biosimilars, and proteins, and also manufactures its own active pharmaceutical ingredients (APIs) such as insulin. Amphastar leverages its state-of-the-art, cGMP-compliant facilities to create innovative drug delivery systems and proprietary technological platforms, targeting difficult-to-produce medications.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-11-06 00:00
Investor Presentation
Q3 2025 Earnings Presentation
English 3.4 MB
2025-09-03 00:00
Investor Presentation
Wells Fargo Healthcare Presentation
English 3.0 MB

Automate Your Workflow. Get a real-time feed of all Amphastar Pharmaceuticals, Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Amphastar Pharmaceuticals, Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Amphastar Pharmaceuticals, Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Bon Natural Life Ltd Logo
Bio-manufactures natural plant ingredients for fragrances, supplements, and immunity solutions.
United States of America
BON
Bosnalijek d.d. Sarajevo Logo
Global manufacturer of drugs for digestive, metabolic, and cardiovascular health.
Bosnia and Herzegovina
BSNL
Boundless Bio, Inc. Logo
Developing ecDNA-directed therapies for intractable oncogene amplified cancers.
United States of America
BOLD
BridgeBio Oncology Therapeutics, Inc. Logo
Clinical-stage biopharma creating small molecule drugs for RAS-dependent cancers.
United States of America
BBOT
BridgeBio Pharma, Inc. Logo
Develops transformative medicines for genetic diseases and genetically driven cancers.
United States of America
BBIO
BRIGHT MINDS BIOSCIENCES INC. Logo
Developing next-gen serotonergic drugs for neurological and psychiatric disorders like epilepsy.
United States of America
DRUG
BRISTOL MYERS SQUIBB CO Logo
Develops innovative medicines for oncology, immunology, and cardiovascular diseases.
United States of America
BMY
R&D pharma firm developing drugs for CNS disorders, oncology, and metabolic diseases.
South Korea
003000
Burning Rock Biotech Ltd Logo
Offers NGS-based diagnostics for precision oncology, from detection to clinical trial support.
United States of America
BNR
C4 Therapeutics, Inc. Logo
Developing protein degrader medicines to treat cancer and other serious diseases.
United States of America
CCCC

Talk to a Data Expert

Have a question? We'll get back to you promptly.